Literature DB >> 19112935

Cholesterol and cholesterol-rich membranes in prostate cancer: an update.

Dolores Di Vizio1, Keith R Solomon, Michael R Freeman.   

Abstract

Cells maintain normal structure and function by responding appropriately to cues from the surrounding milieu. Extracellular stimuli are transduced from the surface through the plasma membrane by a complex series of interactions between ligands, their receptors and intracellular signaling partners (e.g., kinases, G proteins). Cholesterol-enriched membrane microdomains, generally referred to as "lipid rafts", exist within the lipid bilayer of all mammalian cells and play an important role in signaling from the cell surface to various subcellular compartments. Lipid rafts have also been implicated in tumor growth and aggressiveness. Epidemiological evidence suggests that the modern Western diet, which contains substantial levels of cholesterol and other fatty substances, promotes prostate cancer progression. Consistent with this idea, prolonged inhibition of the cholesterol synthesis pathway by pharmacologic intervention in men has recently been associated with reduction in risk of advanced prostate cancer. In this review, we discuss the possibility that membrane cholesterol promotes prostate cancer progression by a mechanism that involves dysregulation of lipid raft-resident signaling complexes. This hypothesis provides new avenues for mechanistic studies as well as therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19112935     DOI: 10.1177/030089160809400501

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  26 in total

1.  Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells.

Authors:  Wen-Chin Huang; Xiangyan Li; Jian Liu; Jentai Lin; Leland W K Chung
Journal:  Mol Cancer Res       Date:  2011-11-07       Impact factor: 5.852

Review 2.  The effect of statins on cancer cells--review.

Authors:  Lucyna Matusewicz; Justyna Meissner; Monika Toporkiewicz; Aleksander F Sikorski
Journal:  Tumour Biol       Date:  2015-05-23

Review 3.  Cholesterol as a potential target for castration-resistant prostate cancer.

Authors:  Alexis L Twiddy; Carlos G Leon; Kishor M Wasan
Journal:  Pharm Res       Date:  2010-08-04       Impact factor: 4.200

4.  The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression.

Authors:  William J Fredericks; Terry McGarvey; Huiyi Wang; Priti Lal; Raghunath Puthiyaveettil; John Tomaszewski; Jorge Sepulveda; Ed Labelle; Jayne S Weiss; Michael L Nickerson; Howard S Kruth; Wolfgang Brandt; Ludger A Wessjohann; S Bruce Malkowicz
Journal:  DNA Cell Biol       Date:  2011-07-08       Impact factor: 3.311

Review 5.  Targeting SREBP-1-driven lipid metabolism to treat cancer.

Authors:  Deliang Guo; Erica Hlavin Bell; Paul Mischel; Arnab Chakravarti
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 6.  The complex interplay between cholesterol and prostate malignancy.

Authors:  Keith R Solomon; Michael R Freeman
Journal:  Urol Clin North Am       Date:  2011-06-22       Impact factor: 2.241

7.  Expression of R132H mutational IDH1 in human U87 glioblastoma cells affects the SREBP1a pathway and induces cellular proliferation.

Authors:  Jian Zhu; Gang Cui; Ming Chen; Qinian Xu; Xiuyun Wang; Dai Zhou; Shengxiang Lv; Linshan Fu; Zhong Wang; Jianling Zuo
Journal:  J Mol Neurosci       Date:  2012-09-26       Impact factor: 3.444

Review 8.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

9.  PPARδ promotes oncogenic redirection of TGF-β1 signaling through the activation of the ABCA1-Cav1 pathway.

Authors:  Nam-Gu Her; Seong-In Jeong; Kyucheol Cho; Tae-Kyu Ha; Jikhyon Han; Kyung-Phil Ko; Soon-Ki Park; Jin-Hee Lee; Min-Goo Lee; Byung-Kyu Ryu; Sung-Gil Chi
Journal:  Cell Cycle       Date:  2013-04-17       Impact factor: 4.534

Review 10.  Phosphoproteomics and cancer research.

Authors:  Keith Ashman; Elena López Villar
Journal:  Clin Transl Oncol       Date:  2009-06       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.